Quarterly report pursuant to Section 13 or 15(d)

Common Shares and Warrants (Details 2)

v3.23.4
Common Shares and Warrants (Details 2) - USD ($)
 1 Months Ended 3 Months Ended 12 Months Ended
May 11, 2023
Oct. 26, 2023
Nov. 30, 2023
Aug. 31, 2023
Common Shares and Warrants        
Beginning Balance, Outstanding     446,936 424,836
Expired/Cancelled     (46,000) (47,500)
Granted     85,000 69,600
Ending Balance, Outstanding     485,936 446,936
Weighted average exercise price, Beginning Balance, Outstanding     $ 3.32 $ 6.45
Ending Balance, Exercisable     474,186  
Weighted average exercise price, Expired/Cancelled     $ 2.98 2.98
Weighted average exercise price, Granted $ 0.95 $ 1.15 1.15 1.75
Weighted average exercise price, Beginning Balance, Outstanding     2.98 $ 3.32
Weighted average exercise price, exercisable     $ 2.97  
Weighted Average Remaining Contractual Term, Outstanding (Years)     3 years 4 months 9 days  
Weighted Average Remaining Contractual Term, Exercisable (Years)     3 years 4 months 13 days  
Aggregate Intrinsic Value, Outstanding     $ 46,025  
Aggregate Intrinsic Value, Exercisable     $ 46,025